Bioadhesive Vaginal Tablet Hydration via Composite Hydrophilic Matrix
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaginal drug delivery systems face challenges such as short residence time, limited drug diffusion due to low vaginal secretions, and local irritation, which hinder effective and controlled drug release, especially with conventional matrix tablets that fail to hydrate adequately in the vaginal environment.
Innovation Solution
The development of bioadhesive controlled release vaginal tablets incorporating a hydrophilic matrix with a disintegrant, such as cellulose ethers and polyacrylic acid derivatives, which accelerates hydration and promotes a rapid solid-gel transition, ensuring efficient drug release and prolonged adhesion to the vaginal epithelium, even with limited secretions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional matrix tablets are used for vaginal delivery, then the structure provides controlled release capability, but the tablets fail to hydrate adequately in the vaginal environment due to limited vaginal secretions
Solution Approach 1:
The patent uses a composite hydrophilic matrix comprising multiple polymers (carboxymethyl cellulose sodium, hydroxypropyl methyl cellulose, and polyacrylic acid) working synergistically. This composite structure ensures adequate hydration and drug release in the limited vaginal secretion environment, resolving the contradiction between maintaining controlled release capability and achieving sufficient hydration.
Solution Approach 2:
The patent modifies the chemical composition parameters of the matrix by incorporating specific ratios of hydrophilic polymers with different hydration properties. This parameter optimization enables the matrix to hydrate effectively in the low-fluid vaginal environment while maintaining its controlled release function.
2Strength
If the drug is highly concentrated in small portions of tablet surfaces, then the tablet structure maintains integrity, but local irritation phenomena occur affecting the vaginal mucosa
Solution Approach 1:
The patent segments the drug distribution within the hydrated matrix, allowing the drug to be released and dispersed across a broader surface area of the vaginal epithelium rather than remaining concentrated at tablet contact points. This segmentation reduces local irritation while maintaining tablet integrity.
Solution Approach 2:
The hydrophilic matrix acts as an intermediary between the concentrated drug in the tablet and the vaginal mucosa. During hydration, the matrix distributes the drug uniformly, preventing direct contact of high drug concentrations with the mucosa and thereby reducing local irritation.
3Productivity
If bioadhesive semi-solid presentations are used, then the drug release is promoted in the vaginal cavity, but the systems require applicators for introduction and show poor physical stability
Solution Approach 1:
The patent designs a self-service system where the vaginal tablet automatically hydrates and releases drug upon insertion, without requiring applicators or complex administration procedures. The tablet's own hydrophilic matrix properties enable it to absorb vaginal secretions and release drug autonomously, simplifying administration while maintaining efficient drug release.
4Duration of action of stationary object
If the residence time in the vaginal cavity is prolonged, then the therapeutic effect is enhanced, but the dosing frequency must be reduced to maintain effectiveness
Solution Approach 1:
The patent achieves continuous useful action through sustained drug release from the hydrophilic matrix over an extended period. The controlled hydration and drug release mechanisms maintain therapeutic drug levels in the vaginal cavity for prolonged residence time, thereby reducing the need for frequent dosing while maintaining treatment effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These tablets achieve a quick onset of action and prolonged therapeutic effect with improved bioadhesion, stability, and controlled drug delivery, reducing dosing frequency and minimizing irritation, while maintaining ease of administration and production costs.
Implementation Method 1
matrix tablets comprising rate controlling excipients made by hydrophilic polymers... Drug release occurs thanks to the swelling properties of the polymers constituting the matrix that hydrates in the presence of aqueous media
Implementation Method 2
inclusion of a disintegrant in an hydrophilic matrix made by one or more ether of cellulose and one or more polyacrylic acid derivatives, promoted a rapid achievement of the swollen state even in presence of limited quantities of vaginal secretions, thereby resulting in a controlled release gel
Implementation Method 3
poor drug diffusion pattern because of the limited quantities of physiological fluids in the vaginal cavity... Drug release occurs thanks to the swelling properties of the polymers constituting the matrix that hydrates in the presence of aqueous media thus exerting the drug release control
Data Source
Figure 1~2
Figure 3~4
AI summary
A hydrophilic matrix is disclosed which comprises: a) at least one polyacrylic acid derivative in preferred amounts of 0.5 - 40%, b) at least one cellulose ether in preferred amounts of 30 - 90% and c) at least one disintegrant in preferred amounts of 2 - 50%, with respect to the weight of the matrix. This matrix is used in combination with at least one pharmaceutically acceptable active principle for manufacturing solid bioadhesive controlled release formulations for the treatment of vaginal disorders, such as vulvovaginal candidiasis, bacterial vaginosis or trichomoniasis. The matrix is used in solid formulations in amounts of about 5 - 60%, preferably 20-40%, and the active principle in amounts of about 2- 70 %, preferably 5-50% with respect to the weight of the formulation.